Friedrich Laub joined Armstrong Teasdale as a partner in its intellectual property practice in New York, the firm announced Monday.
Laub develops and implements global IP and patent strategies across the biopharmaceuticals, biotechnology, and molecular- and immuno-diagnostics industries, the firm said. He also advises clients on IP transactional matters, such as collaboration, licensing, and mergers and acquisitions deals.
This story was produced by Bloomberg Law Automation.
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.